ESMA publishes MiFID compliance function peer review results
The European Securities and Markets Authority (ESMA) has published the results of its Peer Review on the Guidelines on certain aspects of the compliance function under MiFID (Guidelines). The Guidelines cover national competent authorities (NCAs) supervision of investment firms’ compliance functions, particularly how those functions carry out risk assessments, monitor compliance obligations, report to senior management and fulfil their advisory role.
The Review found a high level of compliance by the majority of EEA national competent authorities (NCAs) with the Guidelines, although significant weaknesses were identified in the supervisory approaches of Cyprus, Iceland and the Netherlands. Additionally, the Review identified a number of good practices by a number of NCAs in their supervision. ESMA will follow up regarding the points of insufficient compliance and partial compliance with the relevant NCAs.
The ESMA Supervisory Convergence Work Programme 2016 included a peer review on the Guidelines to assess compliance by the NCAs, identify good practices and potential areas for improvement.
The work involved assessing the approaches of thirty-one EEA NCAs to supervising investment firms’ compliance functions, against the Guidelines requirements, and covered the period from 1 July 2014 to 30 June 2016. The assessment also involved on-site visits of the NCAs from Austria, Cyprus, Denmark, France and Slovakia.
The Review positively assessed 27 NCAs regarding the supervision of how the compliance function performs risk assessments, monitors compliance obligations and provides reports to senior management. While 22 NCAs were positively assessed on their supervision of the compliance function’s advisory role, which includes support for staff training, day-to-day assistance for staff and participating in the establishment of new policies and procedures within the investment firm.
ESMA found diversity in the supervisory approaches applied by NCAs, showing a different reliance on the compliance function as a key source of information on the firms’ compliance with MiFID requirements. For many authorities the compliance function was generally not the main target in supervisory reviews but an ancillary target of supervision of firms’ obligations under MiFID.
Good practices identified
Good practices identified during the peer review will help in enhancing supervisory convergence across EEA NCAs. Key good practices identified included:
- the pre-screening by NCAs of compliance officers;
- clear communications by NCAs of expectations to the compliance function at the authorisation stage; and
- NCAs undertaking on-site visits shortly after the firm’s authorisation, in particular for riskier firms.
The report provides a detailed assessment of the effective application of the Guidelines and the capacity of the NCAs to respond to market developments. It also assesses the capacity of NCAs to achieve high quality supervisory outcomes, including the adequacy of resources.
Related Documents ]
Peer Review On Mifid Compliance Press Release
29 November 2017
ESMA71-99-661_PEER_REVIEW_ON_COMPLIANCE_PR.PDF (149.89 KB)
Peer Review On Certain Aspects Of The Compliance Function Under Mi-fid I
29 November 2017
ESMA42-111-4285_PEER_REVIEW_ON_CERTAIN_ASPECTS_OF_THE_COMPLIANCE_FUNCTION_UNDER_MI-FID_I.PDF( 1.25 MB)
Latest News from
Council and Parliament reach provisional agreement on new EU waste rules18/12/2017 16:25:00
The Estonian presidency hasreached a provisional agreement with representatives of the European Parliament on all four legislative proposals of the waste package.
Europe – the continent of solidarity18/12/2017 15:25:00
Statement on the occasion of International Migrant Day
European Council meetings of 14 and 15 December 201718/12/2017 14:10:00
Remarks by President Jean-Claude Juncker following the European Council meetings of 14 and 15 December 2017
Modified-release paracetamol-containing products to be suspended from EU market18/12/2017 13:15:00
The CMDh has endorsed, by majority, a European Medicines Agency recommendation to suspend marketing of modified- or prolonged-release products containing paracetamol (designed to release paracetamol slowly over a longer period than the usual immediate-release products).